The utility of thromboelastography in monitoring low molecular weight heparin therapy in the coronary care unit
- 1 June 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Blood Coagulation & Fibrinolysis
- Vol. 23 (4), 304-310
- https://doi.org/10.1097/mbc.0b013e32835274c0
Abstract
Low molecular weight heparins (LMWHs) are used for prevention and management of vascular thrombosis. In general, monitoring of anticoagulant activity is not required, however, certain populations may be susceptible to overdosing or underdosing. As anti-activated factor X(anti- Xa) activity testing is not readily available, it was our aim to investigate the usefulness of thromboelastography (TEG; Haemoscope Corporation, Skokie, Illinois, USA) for the assessment of coagulation in patients on LMWH. All patients admitted to the coronary care unit on therapeutic dose of enoxaparin were included (1 mg/kg twice daily). Blood samples were collected 4 h after the morning dose of enoxaparin once the participant had received at least three doses. When anti-Xa activity was classified as low (0-0.5), correct (0.5-1.0) or high (>1.0), the distribution of reaction time (R) and dose per kg showed little association with anti- Xa activity. The difference between mean R for the high anti- Xa group and the correct anti-Xa group was statistically nonsignificant using two-sample t-test (PU0.26). A linear regression model showed no evidence of association between dose per kg and anti-Xa (PU0.95). However, there was evidence of positive association between dose per kg and R (PU0.011) wherein a 10% increase in dose per kg was associated with an increase in R of 2.7 (95% confidence interval 0.6-4.7). There was no evidence of association between R and anti-Xa (PU0.38). TEG was unable to be used to predict anti-Xa activity. However, TEG R was prolonged in more than 90% patients and correlated with dose of enoxaparin. As enoxaparin dose correlated poorly with anti-Xa activity, a more global test might be necessary to adjust dosing of LMWH in sick, hospitalized patients.Griffith Health, School of MedicineNo Full TexKeywords
This publication has 29 references indexed in Scilit:
- Determination of enoxaparin with rotational thrombelastometry using the prothrombinase-induced clotting time reagentBlood Coagulation & Fibrinolysis, 2010
- Application of basic and composite thrombelastography parameters in monitoring of the antithrombotic effect of the low molecular weight heparin dalteparin: an in vivo studyThrombosis Journal, 2009
- How useful is determination of anti-factor Xa activity to guide bridging therapy with enoxaparin?Thrombosis and Haemostasis, 2009
- Effects of nadroparin, enoxaparin, and unfractionated heparin on endogenous factor Xa and IIa formation and on thrombelastometry profilesBlood Coagulation & Fibrinolysis, 2009
- Inhibition of clot formation process by treatment with the lowmolecular-weight heparin nadroparin in patients with carotid artery disease undergoing angioplasty and stenting - A thromboelastography study on whole bloodThrombosis and Haemostasis, 2007
- Fixed dosage of low‐molecular‐weight heparins causes large individual variation in coagulability, only partly correlated to body weightJournal of Thrombosis and Haemostasis, 2006
- In vitro comparison of the effect of fondaparinux and enoxaparin on whole blood tissue factor-triggered thromboelastography profileThrombosis and Haemostasis, 2004
- Thromboelastography as a Perioperative Measure of Anticoagulation Resulting from Low Molecular Weight Heparin: A Comparison with Anti-Xa ConcentrationsAnesthesia & Analgesia, 2000
- Occurrence of thrombosis and haemorrhage, relationship with anti‐Xa, anti‐IIa activities, and D‐dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgeryBritish Journal of Haematology, 1999
- Usefulness of Thrombelastography for Dosage Monitoring of Low Molecular Weight Heparin and Unfractionated Heparin During HemodialysisArtificial Organs, 1990